Metastasis and biophysics of clusters of circulating tumor cells in the microcirculation
Metastasis and biophysics of clusters of circulating tumor cells in the microcirculation
批准号:
10429911
负责人:
Daniel A. Haber
金额:
$59.49万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-08 至 2023-04-30
关键词:
AdhesionsAffectBehaviorBiologicalBiological ModelsBiologyBiomechanicsBiophysicsBloodBlood CirculationBlood capillariesBlood flowBreastCaliberCell AdhesionCell Adhesion MoleculesCell CommunicationCell Culture TechniquesCell NucleusCell-Matrix JunctionCellsClinicalComputer ModelsComputer SimulationDNADNA DamageDistantEndothelial CellsEpithelialEventFibroblastsGeneticGenomic InstabilityGeometryGlycocalyxGoalsHeritabilityHumanImmunodeficient MouseIn VitroIndividualLiquid substanceLocalized Malignant NeoplasmMalignant NeoplasmsMechanical StressMechanicsMesenchymalMesenchymal Cell NeoplasmMethodsMicrocirculationMicrofluidic MicrochipsMicrofluidicsModelingMolecular AbnormalityMusNeoplasm Circulating CellsNeoplasm MetastasisNuclearNuclear EnvelopeOrganPatientsPhenotypePlayPrimary NeoplasmPrognosisProliferatingPropertyProstateResolutionRoleRuptureSpecimenStressStructureTestingTissue EngineeringTravelTumor Cell Biologybiophysical propertiescancer cellcombatconstrictionexperienceinhibitormalignant breast neoplasmmicronucleusmigrationmolecular imagingmouse modelneoplastic cellnext generationprogramsrepairedresponsetumortumor progressionviscoelasticity
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Circulating tumor cells drive metastasis when they travel from primary tumors to distant organs via the
circulation. Multicellular clusters of circulating tumor cells though less frequently observed in blood, are
much more likely to establish metastases than individual circulating tumor cells and the presence of tumor
clusters in blood has been associated with dramatically worse prognoses in patients. Although there are
many suspected explanations for their greater metastatic potentials, much is still unknown about the
behavior of clusters, especially in the narrow vessels of the body. Recent evidence has demonstrated that
cluster transiting through narrow constrictions experience dynamic changes to structure and organization.
Forces in the microcirculation cause clusters to reversibly re-organize into single-file chains to enable
transit through narrow capillary-sized vessels and nuclear envelopes are ruptured and rapidly repaired
during migration events through narrow constrictions. Two biophysical parameters within clusters,
cellular adhesion strengths and nuclear mechanics, are vital for these behaviors. Because of the important
role that these parameters play in many aspects of metastatic progression, we hypothesize that these
parameters modulate the biophysical responses of clusters to physical forces in the microcirculation, and
that these interactions play a significant role in the competitive edge that clusters have edge over
individual cancer cells for seeding metastases. To this end, we propose three specific aims. In aim 1, we
will develop next generation models of the human microcirculation with rounded networks of endothelial
cell coated microfluidic devices and geometry matched computational simulations. In aim 2, we will
explore how intercellular adhesions affect the biophysical responses and metastasis-forming abilities of
homogeneous versus heterogeneous clusters in the microcirculation through the use of our developed
models. Finally, in aim 3 we will study the physical basis for nuclear envelope rupture, DNA-damage,
genetic instability and other DNA-level affects that are involved in metastatic progression. Understanding
the interplay between the biophysics and biology of clusters within the microcirculation will elucidate
mechanisms that can be used to combat the progression of cluster-initiated metastases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microfluidic sorting of lung cancer cells from leukapheresis product as an alternative to metastatic tumor biopsy
-
批准号:10673075
-
项目类别:
-
资助金额:$44.33万
-
财政年份:2021
-
负责人:Daniel A. Haber
-
依托单位:
High-flow microfluidics of leukapheresis blood products for functional analysis of breast circulating tumor cells
-
批准号:10544808
-
项目类别:
-
资助金额:$63.47万
-
财政年份:2021
-
负责人:Daniel A. Haber
-
依托单位:
Microfluidic sorting of lung cancer cells from leukapheresis product as an alternative to metastatic tumor biopsy
-
批准号:10199185
-
项目类别:
-
资助金额:$45.23万
-
财政年份:2021
-
负责人:Daniel A. Haber
-
依托单位:
High-flow microfluidics of leukapheresis blood products for functional analysis of breast circulating tumor cells
-
批准号:10327299
-
项目类别:
-
资助金额:$63.19万
-
财政年份:2021
-
负责人:Daniel A. Haber
-
依托单位:
Microfluidic sorting of lung cancer cells from leukapheresis product as an alternative to metastatic tumor biopsy
-
批准号:10455704
-
项目类别:
-
资助金额:$44.33万
-
财政年份:2021
-
负责人:Daniel A. Haber
-
依托单位:
Metastasis and biophysics of clusters of circulating tumor cells in the microcirculation
-
批准号:9924267
-
项目类别:
-
资助金额:$60.7万
-
财政年份:2018
-
负责人:Daniel A. Haber
-
依托单位:
Metastasis and biophysics of clusters of circulating tumor cells in the microcirculation
-
批准号:10152522
-
项目类别:
-
资助金额:$53.46万
-
财政年份:2018
-
负责人:Daniel A. Haber
-
依托单位:
P1 - Clinical Correlations of WTX Inactivation in Wilms Tumor
-
批准号:8079677
-
项目类别:
-
资助金额:$26.94万
-
财政年份:2010
-
负责人:Daniel A. Haber
-
依托单位:
Point-of care Microfluidics for Early Detection of Cancer
-
批准号:8999413
-
项目类别:
-
资助金额:$172.16万
-
财政年份:2010
-
负责人:Daniel A. Haber
-
依托单位:
Data Production, and Informatics and Integration
-
批准号:8125843
-
项目类别:
-
资助金额:$86.5万
-
财政年份:2010
-
负责人:Daniel A. Haber
-
依托单位:
Clinical Correlations of WTX Inactivation in Wilms Tumor
-
批准号:7742536
-
项目类别:
-
资助金额:$27.02万
-
财政年份:2009
-
负责人:Daniel A. Haber
-
依托单位:
Circumventing Acquired Resistance to Growth Factor Receptor Kinase Inhibitors
-
批准号:7912612
-
项目类别:
-
资助金额:$35.04万
-
财政年份:2009
-
负责人:Daniel A. Haber
-
依托单位:
Circumventing Acquired Resistance to Growth Factor Receptor Kinase Inhibitors
-
批准号:8019551
-
项目类别:
-
资助金额:$35.63万
-
财政年份:2008
-
负责人:Daniel A. Haber
-
依托单位:
Modeling and Circumventing EMT to Suppress Metastasis
-
批准号:8826042
-
项目类别:
-
资助金额:$35.8万
-
财政年份:2008
-
负责人:Daniel A. Haber
-
依托单位:
Modeling and Circumventing EMT to Suppress Metastasis
-
批准号:8502812
-
项目类别:
-
资助金额:$35.8万
-
财政年份:2008
-
负责人:Daniel A. Haber
-
依托单位:
Circumventing Acquired Resistance to Growth Factor Receptor Kinase Inhibitors
-
批准号:8215774
-
项目类别:
-
资助金额:$35.63万
-
财政年份:2008
-
负责人:Daniel A. Haber
-
依托单位:
Modeling Metastasis and Acquired Drug Resistance Using Circulating Tumor Cells
-
批准号:10374103
-
项目类别:
-
资助金额:$36.67万
-
财政年份:2008
-
负责人:Daniel A. Haber
-
依托单位:
Circumventing Acquired Resistance to Growth Factor Receptor Kinase Inhibitors
-
批准号:7780378
-
项目类别:
-
资助金额:$36.73万
-
财政年份:2008
-
负责人:Daniel A. Haber
-
依托单位:
Circumventing Acquired Resistance to Growth Factor Receptor Kinase Inhibitors
-
批准号:7461079
-
项目类别:
-
资助金额:$36.42万
-
财政年份:2008
-
负责人:Daniel A. Haber
-
依托单位:
Modeling Metastasis and Acquired Drug Resistance Using Circulating Tumor Cells
-
批准号:9920676
-
项目类别:
-
资助金额:$37.42万
-
财政年份:2008
-
负责人:Daniel A. Haber
-
依托单位:
海外基金